Javitt Jonathan C
Insider CIK 1303782 · NRXP Chief Scientist, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NRXP NRX Pharmaceuticals, Inc. | A Award deriv | 2025-04-09 | 2025-09-10 | 125,000 | — | $0 | 125,000 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | P Buy | 2024-12-17 | 2024-12-18 | 40,000 | $1.17 | $46.8K | 84,634 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | P Buy | 2023-08-23 | 2023-08-24 | 100,000 | $0.33 | $33.0K | 446,332 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | P Buy | 2023-08-22 | 2023-08-23 | 200,000 | $0.32 | $64.0K | 346,332 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | S Sale | 2022-12-07 | 2022-12-09 | 400,000 | $1.00 | $400.0K | 12,899,997 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | P Buy | 2022-06-01 | 2022-06-02 | 100,000 | $58.00 | $5.80M | 146,332 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | P Buy | 2022-06-01 | 2022-06-02 | 100,000 | $0.58 | $58.0K | 146,332 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award | 2021-05-24 | 2021-06-10 | 46,332 | — | $0 | 46,332 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award | 2021-05-24 | 2021-06-10 | 1,422,000 | — | $0 | 1,422,000 | SEC↗ |
| NRXP NRX Pharmaceuticals, Inc. | A Award | 2021-05-24 | 2021-06-10 | 13,348,997 | — | $0 | 13,348,997 | SEC↗ |